Joint ventures/collaborations « Science and Enterprise

Venture Capital Group to Boost Climate Actions

By Alan, on April 25th, 2023%

A venture investor coalition in the U.S. and Europe announced plans to reach net zero emissions by 2030 and help start-up companies quickly achieve their zero emissions goals. . . . → Read More: Venture Capital Group to Boost Climate Actions

Biotech Partners on Synthetic Proteins to Protect Crops

By Alan, on April 24th, 2023%

A developer of synthetic antibody-like proteins for protecting crops is collaborating with a global agricultural chemical company on sustainable biologic insect controls. . . . → Read More: Biotech Partners on Synthetic Proteins to Protect Crops

Biotech, Undersea Researchers Partner on Carbon Capture Bacteria

By Alan, on April 19th, 2023%

A microbiome biotechnology company and an undersea research group are studying microorganisms that thrive in and consume intense carbon dioxide. . . . → Read More: Biotech, Undersea Researchers Partner on Carbon Capture Bacteria

Biotech, Dairy Company Collaborate on Plant-Based Cheese

By Alan, on April 12th, 2023%

A maker of consumer dairy products and biotechnology food start-up are partnering on plant-based cheeses they say are indistinguishable from today’s dairy cheese. . . . → Read More: Biotech, Dairy Company Collaborate on Plant-Based Cheese

Biotechs Partner to Boost mRNA Manufacturing

By Alan, on April 3rd, 2023%

Two companies working in synthetic biology are advancing a new process they say increases the scale and reduces costs of messenger RNA manufacturing. . . . → Read More: Biotechs Partner to Boost mRNA Manufacturing

Industry, Academic Labs Detailing ALS Treatment Actions

By Alan, on March 27th, 2023%

Researchers from a developer of neurodegenerative disease therapies and university medical center are investigating the precise workings of a promising ALS treatment. . . . → Read More: Industry, Academic Labs Detailing ALS Treatment Actions

Screening Device Company Kicks-Off Type 1 Diabetes Network

By Alan, on March 24th, 2023%

A developer of a blood-testing device that screens for kidney disease risks is the first company to join a network to advance new technology for type 1 diabetes. . . . → Read More: Screening Device Company Kicks-Off Type 1 Diabetes Network

Moderna, Biotech Partner on Non-Viral Genetic Drug Delivery

By Alan, on March 23rd, 2023%

Two biotechnology companies are collaborating on creating genetic therapies delivered with lipid nanoscale particles using non-viral mechanisms to reach target cells. . . . → Read More: Moderna, Biotech Partner on Non-Viral Genetic Drug Delivery

Trial to Test Low-Dose Psilocybin for Mental Distress

By Alan, on March 21st, 2023%

A developer of mental health therapies from psychedelic compounds says it received FDA clearance for a clinical trial testing low doses of psilocybin. . . . → Read More: Trial to Test Low-Dose Psilocybin for Mental Distress

Standard Electronic Biomarkers Validated for Schizophrenia

By Alan, on March 17th, 2023%

A new study validates standard electronic instrument measures of healthy individuals and people with schizophrenia to enable reliable clinical trials for treating the disease. . . . → Read More: Standard Electronic Biomarkers Validated for Schizophrenia

Subscribe for email alerts

Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Like us on Facebook

Specials

Guest Posts

Please share Science & Enterprise